VEGFA and endometrial carcinoma: The ECC-1 line was chosen because it represents a well-differentiated, estrogen-responsive endometrial carcinoma subtype that stably expresses key apoptotic and angiogenic markers such as HIF-1α, VEGF, Bax, and Bcl-2, making it an appropriate model for hypoxia-related investigations.